
Keywords: AML, acute myeloid leukaemia; AraC, Cytarabine; BIR, Baculovirus IAP Repeat; CBF, core-binding factor; CI, combination index; cIAP1, cellular inhibitor of apoptosis protein 1; FACS, fluorescence-activated cell-sorting; FADD, FAS-associated death domain pr